Imagion Biosystems Limited (IBX.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 01:32PM AEST
| Previous close | 0.0280 |
| Open | 0.0270 |
| Bid | 0.0240 x 0 |
| Ask | 0.0290 x 0 |
| Day's range | 0.0230 - 0.0270 |
| 52-week range | 0.0230 - 0.7200 |
| Volume | |
| Avg. volume | 70,334 |
| Market cap | 819,871 |
| Beta (5Y monthly) | 2.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings date | 30 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireImagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent
Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility of MagSense® HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for the assessment of axillary lymph node metastasis in patients diagnosed with HER2+ primary breast cancer. The trial met its endpoint of safety and tolerability, and showed that blinded radiologists may be able to distinguish suspicious lymph nodes that a
© 2024 Yahoo. All rights reserved.